Newron Pharmaceuticals Spa operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Newron Pharmaceuticals Spa with three other
miscellaneous service companies in Europe:
Bioinvent International AB
sales of 38.55 million Swedish Kronor [US$4.17 million]
of which 100%
was Drug Development),
Heidelberg Pharma Ag
(3.67 million Euro [US$4.14 million]
based in Germany
(4.17 million Euro [US$4.72 million]
Sales fell dramatically in 2018:
During the year ended December of 2018, sales at
Newron Pharmaceuticals Spa were 4.03 million Euro (US$4.55 million).
decrease of 69.7%
versus 2017, when the company's sales were 13.29 million Euro.